Matthew Boyd Scratched From Start Due To Recurred Elbow Soreness
TODAY: The Tigers have placed Boyd on the 10-day injured list with a left elbow sprain, per the team. Ian Krol will have his contract selected from Triple-A to claim Boyd’s roster spot. Krol made 12 appearances with the Tigers previously before being designated for assignment and outrighted to Triple-a.
Sept. 10: Tigers left-hander Matthew Boyd was scratched from tonight’s scheduled start due to recurred soreness in his left elbow, tweets Jason Beck of MLB.com. Boyd was on the injured list from June 15 through Aug. 29 with discomfort in his left arm. Boyd will be placed back on the injured list, tweets Evan Woodbery of MLive.com.
It’s a tough blow for both Boyd and the Tigers. The 30-year-old southpaw has had a nice rebound from an awful 2020 season, pitching to a 3.89 ERA in 78 2/3 frames this season when healthy enough to take the mound. Boyd didn’t look great in his return from his recent IL stint, however, as he pitched just eight innings across two starts and yielded a total of seven earned runs.
Had Boyd remained healthy, he would’ve been one of the most asked-about players on this summer’s trade market — at least the second time in his career he’d have held that distinction. Clubs have looked into the possibility of trading for Boyd for several seasons now as the Tigers have been mired in a lengthy rebuild, but a deal has never come together.]
Interest in Boyd was likely at its peak in 2019, when he got out to a dominant start with a 2.85 ERA, a 30 percent strikeout rate and a 5.1 percent walk rate through his first dozen starts (72 2/3 innings). That showing was all the more impressive given the home-run boom that stemmed from what was widely believed to be a juiced ball during the ’19 campaign.
With more than three years of team control remaining at that point in 2019, the Tigers put an understandably sky-high price on Boyd, whose performance began to deteriorate in June and July. Boyd was still missing bats in droves and limiting walks, but like so many pitchers around the league, the home-run ball began catching up with him as the weather warmed. From June 1 through the trade deadline that year, Boyd notched a brilliant 90-to-15 K/BB ratio but yielded 15 home runs and was tagged for a 5.28 ERA in 59 2/3 innings. The Tigers didn’t find an offer to their liking and held onto Boyd.
It was defensible at the time, given that Boyd could be shopped in the offseason or even at any of the subsequent trade deadlines. No deal came together in the 2019-20 offseason, as Boyd never really regained his footing down the stretch that year. Any hopes of capitalizing on a strong few months to open the 2020 campaign were dashed both by the Covid-19 pandemic shortening the season and by Boyd’s rough first few starts of the season. This year, it was an injury that prevented a deal from potentially coming together.
Given the uncertainty surrounding Boyd’s health now, it could prove tough to find a significant return in a trade even if the renewed elbow issue proves minor. And, given the Tigers’ shift from a rebuilding club toward contending — owner Chris Ilitch has already suggested the team will spend this offseason — it’s perhaps likeliest that Boyd returns for what he and the club can only hope will be a healthier 2022 season.
Boyd’s lifetime 4.96 ERA and 4.66 mark over the past few seasons don’t exactly jump out, but he’s frequently shown all the pieces necessary to take his game to a new level. Boyd has regularly shown the ability to miss bats and limit walks, but he’s typically been rather home-run prone. This season, he looked to have the home-run issues curbed, but his strikeout rate dipped to 19.9 percent — his lowest mark since 2017. There are undoubtedly teams that view Boyd as a candidate to put everything together and break out as a strong mid-rotation arm (if not more). Being able to showcase that in a healthy 2022 campaign is now the best-case scenario for Boyd, however.
MLB, MLBPA Agree To Extend Trevor Bauer’s Administrative Leave Through Postseason
Major League Baseball and the MLB Players Association have agreed to extend the administrative leave of Dodgers right-hander Trevor Bauer through the end of the World Series, reports ESPN’s Jeff Passan (Twitter thread). MLB Network’s Jon Heyman suggested earlier this morning that Bauer’s leave was likely to be extended through season’s end.
The agreement between the league and the players’ union does not come in the wake of new information and is largely a procedural move. Bauer hasn’t pitched in a game since late June and would’ve been unlikely to have sufficient time to ramp up again even if a resolution in his case appeared near. There’s no indication, however, that a resolution is on the horizon.
A Los Angeles judge recently denied a permanent restraining order to the woman who has accused Bauer of sexually assaulting her, although that was a civic hearing that is separate from the still-ongoing criminal investigation. The judge ruled that Bauer did not pose a future threat to the alleged victim, but that ruling was not a determination of criminal culpability (or lack thereof).
Criminal charges have not yet been filed against Bauer, nor has he been declared guilty or not guilty. The Pasadena Police recently turned over its findings to the Los Angeles County District Attorney, whose office is still reviewing all of the evidence. Notably, Bill Shaikin of the Los Angeles Times tweets that the DA’s office has not yet determined whether criminal charges will formally be filed.
Major League Baseball is in the midst of its own investigation into these allegations as well as a separate set of accusations from an Ohio woman, stemming from an alleged incident last summer. Commissioner Rob Manfred has the ability to suspend Bauer even if criminal charges are not brought forth. Presumably, the league is waiting on the criminal investigation into Bauer to play out before announcing its own decision.
Bauer was originally placed on paid administrative leave back on July 2. It’s not a punitive measure but is instead implemented to allow Major League Baseball to look into incidents that fall under the purview of the Joint Domestic Violence, Sexual Assault and Child Abuse policy agreed upon by MLB and the MLBPA. Administrative leave is typically only extended in seven-day increments and must be jointly agreed upon by the league and the union. The two parties have agreed to extend Bauer’s leave each Friday since his original leave was announced, but given the proximity to the end of the regular season and the ongoing nature of investigations, an agreement has now been reached to formally close the book on his 2021 season.
Rays Prospect Cole Wilcox Undergoes Tommy John Surgery
Top Rays pitching prospect Cole Wilcox underwent Tommy John surgery on Wednesday this week, reports Marc Topkin of the Tampa Bay Times (Twitter link). That’ll quite likely wipe out his entire 2022 campaign.
Wilcox, 22, came to the Rays as one of the key young pieces in the trade that sent lefty Blake Snell to San Diego. He was a third-round pick, selected No. 80 overall, just last summer — although that draft placement is somewhat misleading. Wilcox, a draft-eligible sophomore last summer, was widely viewed as a first-round talent but slipped down the draft board due to signability concerns. The Friars gave him a $3.3MM signing bonus — a record number for a third-round selection.
The Padres added Wilcox to their 60-man player pool last year and let him work out with at their alternate site over the course of the summer, but last year’s nixed minor league season meant that the former Georgia Bulldogs righty didn’t make his professional debut until this year with the Rays’ Class-A affiliate. Wilcox looked every bit like a first-round talent when cruising through A-ball lineups. In 44 1/3 innings, he pitched to a 2.03 ERA with an impressive 29.9 percent strikeout rate and an incredibly low 2.9 percent walk rate.
Wilcox only recently turned 22, so he’ll still be just 23 years of age when he returns to the mound — presumably early in the 2023 campaign. Obviously, it’s not ideal for a promising young pitcher to effectively lose two seasons of development (2020 and 2022, in this case), but Wilcox has age on his side. Assuming he’s able to pitch a mostly full season in 2023, he’ll likely be added to Tampa Bay’s 40-man roster in the 2023-24 offseason, as he’d otherwise be eligible for the Rule 5 Draft that winter.
Even with Wilcox sidelined next season, the Rays have an impressive crop of rising young arms to tap into both in 2022 and in 2023. Luis Patino (also acquired in the Snell deal) and Shane McClanahan have already made an impact at the MLB level, and top prospect Shane Baz likely isn’t too far behind. Right-hander Seth Johnson, like Wilcox, has yet to pitch beyond Class-A, but the 2019 No. 40 overall selection has upped his prospect stock with an outstanding showing in A-ball this season.
Tampa Bay did trade away a pair of nearly MLB-ready arms — Joe Ryan and Drew Strotman — in order to acquire Nelson Cruz, but it seems we can scarcely go a year without a pop-up pitching prospect or two in the Rays’ perennially deep farm system garnering national attention. Recent trades and the loss of Wilcox notwithstanding, the Rays still boast a deep farm system that’ll continue to be ranked among the game’s best.
Chris Sale Tests Positive For Covid-19
Red Sox Chris Sale has tested positive for Covid-19 and will not make his scheduled start Sunday, per Chris Cotillo of MassLive.com (via Twitter). He’ll be placed on the Covid-19-related injured list, joining eight other Red Sox players who have either tested positive or are in protocol due to the recent team outbreak in Boston.
Major League Baseball’s health-and-safety protocols for the 2021 season stipulate that Sale will be away from the club for at least 10 days, further straining a rotation that has been heavily impacted by the team’s outbreak. Both Nick Pivetta and Martin Perez are currently on the Covid-related injured list, which has prompted recent starts from Kutter Crawford and Brad Peacock. Perez has been on the IL since Aug. 30 and could be nearing a return, and the Sox also currently have Eduardo Rodriguez, Nathan Eovaldi and Tanner Houck in the rotation. The Boston Globe’s Peter Abraham further reports that it’s also possible Pivetta could be activated to make Sale’s start Sunday.
The 32-year-old Sale missed the bulk of the 2021 season as he worked his way back from Tommy John surgery but has been excellent in five starts since rejoining the team. He’s yet to pitch beyond the sixth inning but carries a 2.52 ERA with a 27.5 percent strikeout rate and 5.5 walk percent rate — both quite strong marks — in his first 25 innings since being activated.
The Red Sox have a fairly tenuous hold on the top Wild Card spot in the American League, leading the Yankees by a margin of just one game. Three more teams — Toronto, Seattle and Oakland — are within two games of that second Wild Card spot and within three games of Boston’s top spot. The Sox have managed to remain in competition despite an outbreak that has seen 10 players test positive since late August.
Sale’s positive test comes less than 24 hours after Red Sox right fielder Hunter Renfroe controversially claimed in a WEEI radio appearance with Lou Merloni and Christian Fauria that Major League Baseball had told the Red Sox to “stop testing and just treat the symptoms” (Twitter link with audio). Asked in a follow-up to confirm that MLB had instructed the Red Sox to stop testing, Renfroe replied with a simple, “Yes.”
Both Major League Baseball and the Red Sox moved quickly to refute the claim. Julian McWilliams and Kate McInerny of the Boston Globe cited a league spokesperson who called Renfroe’s claim “completely wrong and inaccurate,” while the team issued a statement indicating it has “been following MLB’s COVID-19 protocols all season long.” The Red Sox added that they have “continued to test and [the league’s] medical staff has been very supportive.”
Renfroe has not further addressed his comments, and there’s been some speculation that he misconstrued the league’s policy of reduced testing frequency for vaccinated, asymptomatic players, which went into place back in June. Under those updated protocols, vaccinated players are not tested for the virus unless they either display symptoms or are deemed a close contact from a person known to have tested positive.
Freeman, Braves Still Facing Gap In Extension Talks
The Braves have extended a pair of veterans in the past few weeks, inking catcher Travis d’Arnaud to a second two-year, $16MM contract and extending right-hander Charlie Morton on a new one-year deal worth $20MM (plus a $20MM club option for the 2023 season). Atlanta fans, of course, are eagerly awaiting a more sizable investment in cornerstone slugger Freddie Freeman, the reigning National League MVP. While the two sides have talked, however, MLB Network’s Jon Heyman tweets that a gap remains, making Freeman increasingly likely to reach the open market at the end of the season, although both parties still hope to ultimately come to an agreement.
That a “gap” exists between the two parties effectively goes without saying. (He’d be signed by now without one.) Still, most Braves fans have been eagerly awaiting a deal, particularly with a pair of recent extensions now on the books, so even the possibility of Freeman actually reaching the market is unsettling. Freeman reaching the free-agent market certainly doesn’t make his departure a foregone conclusion. Talks with other clubs would only increase his leverage in negotiations with the Braves, potentially helping his cause on an eventual new contract.
Freeman, who’ll turn 32 on Sunday, is playing out the final season of an eight-year, $135MM contract extension that, at the time, was an enormous deal relative to contracts signed by peers with similar service time. The Braves were effectively paying full market value for Freeman despite him being years from the open market, and yet it’s still turned out to be a major bargain for the five-time All-Star. Freeman got out to a “slow” start (by his standards, anyway), but he’s absolutely dominated since mid-June. Over the past three calendar months (admittedly, an arbitrary cutoff point), Freeman is hitting .341/.417/.554 with 16 home runs, 15 doubles and a triple in 348 plate appearances.
On the whole, Freeman is hitting .293/.388/.505 with 29 big flies this season. It’s a step down from last season’s ludicrous .341/.462/.640 batting line through all 60 games but is nevertheless exceptional production. That he’ll turn 32 is surely a concern for the Braves, but as has been pointed out here and many other places in the past, it was just two years ago that fellow All-Star first baseman Paul Goldschmidt inked a five-year, $130MM contract extension with the Cardinals that kicked off in his own age-32 season.
That contract is surely a point of comparison for Freeman and his reps at Excel Sports Management. Given last season’s MVP nod and a recent track record that’s even more productive than the excellent run Goldschmidt had leading into his own extension, it wouldn’t be a surprise if Freeman’s camp is looking to top that mark.
From a payroll vantage point, there’s no real difficulty fitting Freeman onto the long-term books. The Braves signed both Ronald Acuna Jr. and Ozzie Albies to wildly team-friendly contracts, and they’ll see veterans Drew Smyly and Chris Martin come off the books in 2022, trimming $18MM in guarantees.
Much of those savings will be reallocated to arbitration raises for next year’s class, but it should also be pointed out that the Braves don’t have too many large raises to give out. Dansby Swanson will surely get a big bump from this year’s $6MM salary, but their only other particularly sizable raises will go to lefty Max Fried and third baseman Austin Riley. Fried is due a raise on this year’s $3.5MM salary, while Riley will be arbitration-eligible for the first time. Not including arbitration raises (but including option buyouts), the Braves currently have about $84MM committed to next year’s payroll, per Roster Resource’s Jason Martinez.
Given their current payroll of about $145MM, a new deal for Freeman is more than manageable. Ostensibly, this very situation is where the early extensions inked by Acuna and Albies ought to pay dividends. Having both stars locked up long-term on below-market deals ought to allow the Braves to pay to keep a player like Freeman, who is nearing franchise icon status, for the bulk (or entirety) of his remaining career.
Of course, the Braves have other long-term prospects to consider. Swanson will be a free agent next winter, and Riley is looking increasingly like a player who could be a foundational piece in his own right. At some point, a hard decision or two will need to be made, but it’d be nothing short of stunning to see Freeman actually depart, even if he does reach the open market.
Latest On Jacob deGrom
SEPTEMBER 9, 5:40 pm: Jon Heyman of the MLB Network reports that there’s only “an outside chance” deGrom will make it back this season.
SEPTEMBER 9, 4:45 pm: deGrom released a statement to reporters (including Mike Puma of the New York Post) this afternoon addressing his health status. “I know what was said and my ligament is perfectly fine. I have been throwing and I wouldn’t be if I had a compromised ligament. That’s the plan to continue to throw and build up and see where we end up.”
SEPTEMBER 8: Mets ace and two-time NL Cy Young winner Jacob deGrom hasn’t pitched in a game for two months now. The Mets, in somewhat typical fashion, have provided vague updates on his health throughout the process, repeatedly citing clean MRIs while simultaneously pushing back throwing sessions and shutting him down for additional spells to provide further relief from the inflammation in his elbow.
However, team president Sandy Alderson revealed to reporters last night that there was indeed something more concerning at play, though he insists the issue has now “resolved itself” (link via Newsday’s Tim Healey). DeGrom, according to Alderson, had the “lowest-grade partial tear” possible in his right ulnar collateral ligament.
That’s a much different outlook than was provided by manager Luis Rojas and acting GM Zack Scott, both of whom said at different points in the recovery process that there was no structural damage in deGrom’s elbow. Scott said back on July 30 there was no damage in the ligament, per Healey, and Rojas made the same assertion on Aug. 13. Clearly, surgery was not deemed necessary in the end, and Alderson insists that the ligament is now “perfectly intact” after two months away from game action. Nevertheless, it’s a rather perplexing contradiction from prior messaging on deGrom’s prognosis.
Any mention of even slight UCL damage for a pitcher is concerning — particularly when it’s regarding someone who has already undergone Tommy John surgery once in his career (prior to his MLB debut, in deGrom’s case). Alderson’s insistence that this is essentially a non-issue at this point could be taken as a sigh of relief for Mets fans, but those comments will be ripe for scrutiny if this does ultimately prove to be a more serious situation down the road.
At last check, the Mets had suggested that a best-case scenario for deGrom would be to appear in a few games late in the season — likely only in “abbreviated” fashion. The latest comments from Alderson don’t do anything to change that trajectory, but the transparency into deGrom’s diagnosis lends some critical context and clarity with regard to the team’s cautious approach in handling him.
DeGrom, 33, has pitched 92 innings this season and logged a superhuman 1.08 ERA with similarly absurd strikeout and walk percentages: 45.1 percent and 3.4 percent, respectively. He’s still owed $64MM from 2022-23 combined (albeit with $27MM of that sum deferred 15 years), and his five-year, $137.5MM contract also contains a $32.5MM club option for the 2024 season. He can opt out of the remaining guaranteed year following the 2022 season.
The Mets trail the Braves by four games in the National League East and are three and a half games behind the Padres and Reds in the Wild Card standings.
Price Of Kyle Seager’s Club Option Has Increased
4:10 pm: Ryan Divish of the Seattle Times reports that the value of Seager’s option has actually escalated all the way to the maximum $20MM figure. According to Divish, Seager needs 37 more plate appearances through the end of the regular season to push the value of the buyout from $1.5MM to $2MM. With 22 games remaining on the schedule, Seattle’s regular third baseman shouldn’t have much difficulty reaching that mark.
9:25 am: Kyle Seager has been a Mariner since the club selected him with the 82nd overall draft pick back in 2009, but the Mariners will soon face a decision on the former All-Star who’s held down the hot corner at T-Mobile Park/Safeco Field for the past decade.
Seager is in the final guaranteed season of a seven-year, $100MM contract extension signed back in December 2014, but that contract holds a club option for the 2022 season. While the option was originally valued at $15MM, Seager’s extension included escalators that could boost the option value up to $20MM and trigger a buyout of as much as $3MM (as MLBTR’s Tim Dierkes reported at the time of the deal). Seager hasn’t reached the full weight of those escalators, but Ken Rosenthal of The Athletic now reports that he’s boosted that option value up to $19MM and hit enough of the escalators to tack on a buyout in the $1.5MM to $2MM range.
Triggering the buyout means that regardless of the Mariners’ decision, Seager will walk away from the deal with at least $101.5MM to $102MM in guaranteed money. For the Mariners, what was previously a net $15MM decision is now a net decision in the $17MM to $17.5MM range.
Seager, 34 in November, has become an increasingly difficult player to value. His .213 batting average and .290 on-base percentage are both obvious eyesores, but he’s also slugging .455 and has clubbed a career-high 34 home runs in 2021 with a few weeks of games yet to play. His 23.7 percent strikeout rate is a career-high, but the league-average strikeout rate has soared in recent years; he’s only one percent north of the 22.7 average for non-pitchers.
Seager has also had at least some degree of poor fortune on balls in play, although perhaps not as much as his career-low .218 BABIP would suggest upon first glance. Seager’s career .272 average on balls in play is already lower than that of the league average (about .300), so we can’t simply assume there will be positive regression all the way up to the league norm.
This version of Seager is naturally going to be prone to a low BABIP due to his pull-happy (45.5 percent) and thus shift-prone approach, a huge 51.6 percent fly-ball rate (including a 13.6 percent infield-fly rate) and his decreasing speed. Statcast pegs Seager’s “expected” batting average at .225, which would be enough to narrowly push his OBP into the .300s assuming the rest of his profile remained the same. Seager, like so many other players in the league, has taken some steps toward a three-true-outcomes style at plate — albeit not to the same dramatic extent as three-true-outcome kings like Joey Gallo or Miguel Sano.
On the defensive side of things, Seager remains a solid option at third base. Both Ultimate Zone Rating (4.0) and Outs Above Average (5) grade him as an above-average defender. Defensive Runs Saved has him at minus-4 this season, but Seager has a long track record of quality DRS marks. His 13 errors have him on pace to finish right around his full-season totals from 2017-19. He’s not Matt Chapman or Nolan Arenado at third base, but most clubs would likely consider him anywhere from serviceable to above-average, which has value in its own right.
The Mariners, at least to some extent, will also have to take into account Seager’s status as a foundational piece for the past decade. Back in February, now-former Mariners president Kevin Mather made a buyout of Seager’s option sound like a fait accompli, indicating that the 2021 campaign would likely be his last as a Mariner. Mather, of course, is no longer with the club and Seager has gone on to belt a career-best 34 dingers — albeit with concerning declines in OBP and average, as previously highlighted. FanGraphs values Seager at 2.6 wins above replacement, putting him on pace to finish as a 2.9-WAR or better player for the ninth time in his past 10 full seasons (i.e., excluding 2020).
The Mariners could simply buy Seager out and slide Abraham Toro (and, on occasion, Ty France) over to third base in 2022. However, both players are capable of playing other positions. Toro has been lined up primarily at second base since being acquired from Houston, and France is capable at both second and first (with more than enough bat to simply DH, as well).
Ultimately, a net price in the $17MM range seems steep for Seager, but the Mariners also only have $19MM in guaranteed salary on the books next season, with a fairly light arbitration class to boot. Combine that with Seager’s career-best power output, solid glovework and legacy status in Seattle — and it’s enough to at least make this a closer decision for the front office than most would expect.
Yankees Place Jameson Taillon On Injured List, Designate Jonathan Davis
The Yankees announced Thursday that they’ve placed right-hander Jameson Taillon on the 10-day injured list, retroactive to Tuesday, with a “right ankle tendon injury.” Right-hander Sal Romano was selected from Triple-A Scranton/Wilkes-Barre in his place, and outfielder Jonathan Davis was designated for assignment to open a spot on the 40-man roster for Romano.
Taillon suffered a partial tear in the tendon in his ankle, manager Aaron Boone told reporters (including Erik Boland of Newsday). While that certainly sounds ominous, Boone suggested there’s optimism Taillon could miss at little as one start before returning. It seems rookie Luis Gil could assume Taillon’s rotation spot for the time being, with Gerrit Cole, Jordan Montgomery, Corey Kluber and Nestor Cortes Jr. rounding out the starting staff.
Acquired from the Pirates over the winter, Taillon got out to a slow start to his Yankees’ tenure. He was tagged for a 5.43 ERA through the end of June, with significant home run troubles offsetting quality strikeout and walk numbers. The 29-year-old was one of the league’s best pitchers in July, though, and has generally been quite productive over the past couple months. Since July 1, Taillon owns a 3.39 ERA as he’s done a better job keeping the ball in the yard. On the season, Taillon has a 4.41 mark across 138 2/3 innings with an average 23.4% strikeout rate and a solid 7.2% walk percentage.
Romano has bounced on and off a few teams’ rosters over the course of the season. He began the year with the Reds, struggling badly in April and finding himself designated for assignment. After clearing waivers, he elected free agency and signed a minor league deal with the Yankees. He was selected to the big league roster but quickly DFA’d again, this time landing with the Brewers via waiver claim. Milwaukee became the third team to bump the right-hander from the 40-man roster not long thereafter, and Romano again elected free agency and signed with the Yankees.
Over his prior three big league stints, Romano compiled a 5.63 ERA in 24 innings of relief. His 13.9% strikeout rate is well below-average for a reliever, as is his 5% swinging strike rate. That said, Romano has been far better with Scranton/Wilkes-Barre, where he’s worked to a 3.56 figure over 30 1/3 innings. His 19.1% minor league strikeout rate is still a few points worse than the league average, but it’s quite a bit better than his big league mark. More impressively, Romano has walked a minuscule 3.8% of batters faced with the RailRiders, so Boone should at least be able to count on him throwing strikes consistently in the middle innings.
The Yankees claimed Davis off waivers from the Blue Jays a little more than a month ago. At the time, New York’s roster was reeling from COVID-19 spread. With those players having recovered from the virus, Davis found himself optioned to Triple-A and eventually squeezed off the 40-man entirely. The Yankees will now place Davis on outright or release waivers in the next few days.
Over parts of four seasons with the Jays and Yankees, Davis owns a .171/.272/.248 mark in 259 plate appearances. The right-handed hitter has a more productive .250/.355/.421 line in three seasons at Triple-A, though, and is capable of playing all three outfield positions. He is in his final minor league option year, so any team that claims Davis could keep him in the high minors as a depth option for the rest of the regular season. Because he’s being designated for assignment after August 31, Davis wouldn’t be eligible for a new team’s postseason roster if he’s claimed off waivers.
Latest Rumors On Mets’ Front Office
The Mets again find themselves in the midst of an effort to reshape their front office, less than a year after already making sweeping changes under new owner Steve Cohen. Team president Sandy Alderson temporarily assumed oversight of baseball operations last week as the team put acting GM Zack Scott on administrative leave following a DWI arrest, but there’s little expectation Alderson will return to the top of the baseball ops hierarchy on a full-time basis.
MLB Network’s Jon Heyman tweets today that Alderson signed a two-year deal to help Cohen’s ownership transition and front office changes, but he had no desire to return to a full-time baseball operations role. The team’s plan for the 2022 season is to have Alderson return to a broader-reaching team president role without directly running the baseball operations department. A new hire will need to be made, as has already been widely suggested in the wake of Scott’s DWI charge.
Cohen’s Mets were connected to numerous high-profile candidates last year in looking to fill their baseball operations void after parting ways with Brodie Van Wagenen, but several either declined to interview or were denied permission to do so. Teams generally only permit their executives to interview with other clubs if the position is a promotion over their current post. It’s probably not a coincidence that the Rays not only extended general manager Erik Neander but promoted him to president of baseball operations just yesterday; Neander was known to be of interest to the Mets last year.
There’s been quite a bit of recent speculation on Theo Epstein as a candidate. The Athletic’s Ken Rosenthal, USA Today’s Bob Nightengale and the New York Post’s Joel Sherman all wrote on the topic within the same 24-hour period. Of course, as Rosenthal pointed out, it was Epstein who originally hired both Scott and Jared Porter — the former Mets GM who was fired a month into his tenure last offseason following revelations of past harassment of a reporter. Both joined the Red Sox under Epstein’s watch, and Epstein brought Porter to Chicago not long after being named Cubs president of baseball operations.
The optics of that aren’t necessarily damning, but a cleaner break from that tree might also be welcome. Furthermore, SNY’s Andy Martino wrote this week that nearly everyone he’s spoken to has strongly downplayed the Epstein rumors. All three Epstein columns also mention the possibility that he’d look to secure a minority stake with any team he joins, and Martino suggests the same: that Epstein is seeking a partial ownership opportunity.
Looking around the league, there aren’t many high-profile executives who’d seem like candidates to depart their current post and take on the spotlight of the Mets’ presidency. Twins GM Thad Levine and Indians GM Mike Chernoff both declined the opportunity to interview last offseason. A’s GM David Forst was reported to be of interest to the Mets (and the Angels), but there’s no indication he ever actually interviewed (or even spoke with) either club.
Heyman somewhat speculatively suggests two other executives whose names have been or could be of interest to the Mets: Dodgers senior vice president of baseball operations Josh Byrnes and Rangers president of baseball operations Jon Daniels. Martino, in similar fashion, listed off three more high-profile execs who’d be making lateral moves and require ownership permission to even interview: Cleveland’s Chris Antonetti, Minnesota’s Derek Falvey and Oakland’s Billy Beane.
Byrnes would make a fairly logical candidate for the Mets to pursue. He’s a high-ranking member of a large-payroll, consistently successful organization, but the Mets’ top baseball ops job would still represent a promotion for him. He’s also served as general manager of both the Padres and the Diamondbacks in the past, so he’s no stranger to running a baseball operations outfit himself. Somewhat coincidentally, Byrnes was the other finalist for the Mets’ GM post back in 2010 when the team ultimately hired Alderson to take over baseball operations.
As for Daniels, he would be making a lateral move, from one president of baseball ops role to another. However, the Rangers also just recently hired Chris Young as their new general manager, and that could be viewed as a means of grooming an eventual heir-apparent for Daniels, who was extended on a contract of still-unreported length back in 2018. Daniels — a Queens native, for what it’s worth — has been running the Rangers’ baseball operations department since being appointed general manager at just 28 years of age in the 2005-06 offseason.
Daniels’ situation bears some similarity to that of Brewers president of baseball operations David Stearns, whose name was recently raised in connection with the Mets by ESPN’s Buster Olney. However, there are also some key differences. As is the case with the Rangers, the Brewers just named a new general manager, Matt Arnold, to serve under Stearns (who is, like Daniels, a New York native). The key difference is that Arnold was promoted to GM from within at a time when the Mets were known to be looking to hire a GM; Young was hired by the Rangers from outside the organization. (Although he also interviewed for the Mets’ job last offseason before joining the Rangers.)
Stearns is also newer to the Brewers’ top job than Daniels is to his own post. His contract extension and promotion are both more recent as well. There’s little reason to think Brewers owner Mark Attanasio would be open to allowing Stearns to depart when he’s still under contract another year and when the Brewers have emerged as one of the best teams in all of baseball. The Brewers denied him permission to interview last offseason, Martino notes.
Suffice it to say, speculation already abounds with regard to the Mets’ front office, and that’s before the team has even truly begun its search for a new baseball operations leader in earnest. These names and a dozen or more others will likely be tied to the Mets in the weeks and months to come, before a hire is ultimately made.
Wade LeBlanc To Undergo Elbow Procedure
The Cardinals have shut left-hander Wade LeBlanc down for the remainder of the season, manager Mike Shildt announced to reporters Thursday (Twitter link via Jeff Jones of the Belleville News-Democrat). He’s expected to undergo some type of procedure to address the elbow pain that has sidelined him, though Shildt was not able to provide specifics. Derrick Goold of the St. Louis Post-Dispatch tweets that LeBlanc is still exploring options. Shildt noted that LeBlanc, a pending free agent, is expected to be ready for Spring Training.
Originally signed back in June with the rotation in shambles, LeBlanc was viewed as little more than a flier on a veteran stopgap at the time. However, he emerged as much more than that, not only providing steady innings but giving the Cardinals his best work since the 2018 season.
LeBlanc, 37, appeared in a dozen games for St. Louis — four relief outings and eight starts — and put together 42 1/3 innings of 3.61 ERA ball. A middling 12.2 percent strikeout rate and 8.5 percent walk rate didn’t inspire much confidence in his ability to sustain that pace, but the innings he provided are in the books and came at a desperately needed time for the Cards.
Shaky strikeout-to-walk profile notwithstanding, LeBlanc’s solid showing in St. Louis ought to earn him another opportunity in 2022, even with some uncertainty regarding his health. An exact timeline on his recovery won’t be known until LeBlanc and the doctors he’s consulting pin down the extent of the procedure he’ll need, but if he’s expected to be ready come Spring Training, it’s easy to envision multiple clubs showing interest on a minor league pact. He’d be a fine depth option for the Cardinals in that regard, and he’s clearly already made a nice impression on the organization.
With LeBlanc out for the remainder of the season and Jack Flaherty again on the shelf with a shoulder strain, the Cardinals will continue relying on Adam Wainwright, Miles Mikolas, Jon Lester and J.A. Happ atop the rotation. Lefty Kwang Hyun Kim and right-handers Jake Woodford and Daniel Ponce de Leon are among the other options to start games down the stretch for a Cardinals club that is buried in the NL Central but sits just three and a half games back of the second Wild Card spot in the National League.